Home › Forums › Valdig.eu website › Anticoagulation options with platelets › Reply To: Anticoagulation options with platelets
22 October 2018 at 12h52
#2112
Audrey Dillon
Participant
Thank you, our main concern is the risk of progression of thrombus, and while I agree that transplant is not necessary for many in this NCPH; we want to ensure that she does not end up non-transplantable due to our inaction, as she is only 25.
She has a 5cm non-occlusive thrombus in the portal vein that stops just above the confluence.
She has a normal bilirubin and albumin, INR 1.2. Her US 2 weeks ago showed no ascites on Spironolactone 200mg.